A Deep Insight into the Correlation Between Gut Dysbiosis and Alzheimer’s Amyloidopathy

0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Recent research has shown a strong correlation between gut dysbiosis and Alzheimer’s disease (AD). The purpose of this review is to investigate the relationship between gut dysbiosis, immune system activation, and the onset of AD and to examine current breakthroughs in microbiota-targeted AD therapeutics. A review of scientific literature was conducted to assess the correlation between gut dysbiosis and AD and the various factors associated. Gut dysbiosis produces an increase in harmful substances, such as bacterial amyloids, which makes the gut barrier and blood-brain barrier more permeable. This leads to the stimulation of immunological responses and an increase in cytokines such as interleukin-1β (IL-1β). As a result, gut dysbiosis accelerates the progression of AD. The review highlights the connection between gut dysbiosis and AD and the potential for microbiota-targeted therapies in AD treatment. Pictorial Abstract: (Figure presented.).

Cite

CITATION STYLE

APA

Kondaveeti, S. N., Thekkekkara, D., Lakshmi Narayanan, T., Manjula, S. N., Tausif, Y. M., Babu, A., & Meheronnisha, S. K. (2022, December 1). A Deep Insight into the Correlation Between Gut Dysbiosis and Alzheimer’s Amyloidopathy. Journal of Pharmacology and Pharmacotherapeutics. Sage Publications India Pvt. Ltd. https://doi.org/10.1177/0976500X221150310

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free